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ABBREVIATIONS 
AFB –acid fast bacilli 
ATS-American Thoracic Society 
BOOP- Bronchiolitis obliterans 
             Organizing pneumonia 
BTS- british thoracic society 
BAC-Bronchialveolar carcinoma 
CAP-community acquired pneumonia 
COP-cryptogenic organizing pneumonia 
COPD-chronic  obstructive  
        Pulmonary disease 
CT-Computed tomography 
CXR-chest radiograph 
FNAC-Fine needle aspiration cytology 
HIV-human immunodeficiency virus 
IDSA-infectious disease society of America 
LRI-Lower respiratory infection 
MDR-multidrug resistance 
NPV-Negative predictive value 
PCP-Polymerase chain reaction 
PPV-Positive predictive value 
RR-Respiratory rate 
USG-Ultrasound 
received an empirical course of antibiotics as suggested by American Thoracic Society 
guidelines. 
INCLUSION CRITERIA   
1. PATIENTS WHO FULFILL THE DIAGNOSIS OF NON-RESOLVING PNEUMONIA(NO 
RADIOLOGICAL RESOLUTION AFTER 4 WEEKS  OF ANTIBIOTICS) 
2. SPUTUM CULTURE NEGATIVE AND SPUTUM FOR AFB NEGATIVE 
3. HIGH CLINICAL AND RADIOLOGICAL  SUSPICION OF LUNG CARCINOMA  
 
EXCLUSION CRITERIA 
 
1. KNOWN PATIENTS OF LUNG CANCER  
2. SPUTUM-POSITIVE PULMONARY TUBERCULOSIS 
3. PATIENTS HAVING VERY POOR GENERAL CONDITION, VERY SEVERE 
BREATHLESSNESS, RECENT 
HISTORY OF MYOCARDIAL INFARCTION. 
4. POSITIVE TEST RESULT FOR HUMAN IMMUNODEFICIENCY VIRUS(HIV) 
INFECTION 
5. UNWILLING PATIENTS WERE OMITTED FROM OUR STUDY. 
 
 
  
STUDY PROTOCOL: 
Clinical, radiological and laboratory tests were performed before initiating empirical 
antibiotics, and after they fail to improve after antibiotic therapy. A STRUCTURED 
PROFORMA was  used.Patients age,sex and smoking history if present were noted.Prior 
investigations,sputum for AFB,sputum culture report and HIV reports were noted down 
.proper consent was obtained from the patients after procedure was explained in their 
local language and consent form duly signed in their local language.All patients who 
were included in the study were hospitalized for a day to look for complication such 
pneumothorax and bleeding.Chest x-ray were done 6 hours after the  
procedure.Standard operating procedure for managing PNEUMOTHORAX was  fixed 
according to British Thoracic society guidelines.Investigations done in this study after 
labelling the patient as patient with non resolving pneumonia  were ultrasound guided 
FNAC done with 21gauge needle and bronchoscopic wash culture and cytology and 
biopsy if warranted. 
 
INSTRUMENTATION: 
ULTRASOUND LT200 MODEL WITH CURVILINEAR PROBE WITH FREQUENCY OF  
3.5MHZ TO 5MHZ WAS USED BY THE PULMONOGISTand chest medicine postgraduates 
who were trained in handling ultrasound.10 ml syringe with 21 gauge needle was used 
for FNA and smear slides were air dried and sent to pathology 
department.Bronchoscopy was done using Olympus fibre optic bronchoscope and 
specimen were collected under standard norms and sent for culture and histopathology. 
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INTRODUCTION 
                   Pneumonia is a common respiratory disorder,which affects all age groups. It is the 
of leading cause of mortality especially among children and causing significant morbidity in 
adults if left untreated. It is leading cause of disability adjusted life years worldwide. 
Epidemiology of pneumonia differs among children and adults and so understanding causes 
and risk factors is very essential for proper diagnosis and treatment. Prevalence and 
incidence of pneumonia vary according to geographical distribution and seasonal pattern 
also. The burden of pneumonia is well illustrated by the quote of William Osler who 
described the disease as the CAPTAIN OF THE MEN OF DEATH. 
                  Pneumonia is common in children aged less than 5 years and becomes 
progressively more common from 40 years onwards with peak incidence in the very  elderly. 
Pneumonia can affect previously healthy individuals, but susceptibility is greatly increased by 
a variety of risk factors(I). This distribution is the result of a complex interrelationship 
between environment, host and socio economic factors. South east Asian WHO region has a 
death of 8 per 10000 due to pneumonia. There is a male dominance in the deaths due to 
pneumonia and highest incidences at extremes of ages. 
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     PNEUMONIA IS DEFINED AS INFLAMMATION OF ONE OR BOTH LUNG PARENCHYMA 
WITH CONSOLIDATION. Cause  is mainly infective but consolidation can be  occur  due  
irritant  gases,  radiation,  allergens,  malignancy.   Community  acquired pneumonia (CAP) is 
a leading cause of hospital admission.  The micro organisms giving rise to CAP may show 
geographical variation, however, in general both  bacteria and viruses are responsible. 
      Classification based on the site of acquisition is important as the responsible organisms 
varies according to where it was acquired. The etiological agent of community acquired 
pneumonia is an important factor for predicting the disease severity and the level of care 
warrented. Pneumococcus and multiorganism infection are the most common causes 
warranting treatment in an intensive care unit in CAP. 
 
 COMMON CAUSES IDENTIFIED INCLUDES: 
 BACTERIA: S. pneumoniae,   H. influenzae, Methicillin sensitive Staph aureus, E. coli, Klebsiella 
pneumoniae, Proteus sp., Enterobacter sp., Serratia marcescens. 
 Respiratory viruses = Influenza A and B viruses, adenoviruses, respiratory syncytial viruses, 
parainfluenza viruses 
 Mycoplasma 
 Chlamydia 
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Figure 1:COMMON CAUSES OF CAP 
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Risk Factors 
       Causative organisms from the upper airways or less commonly from hematogenous 
spread or direct spread from a contiguous focus find their way to lung parenchyma. 
Conditions such as altered sensorium, stroke facilitate aspiration of contents into lungs. Loss 
of upper airway reflexes such cough, impairment of local defence mechanism such as 
mucosal blanket which is lost due smoking and irritants ,factors that destroy alveolar 
epithelium such tobacco smoking, bronchial metaplasia or neoplasia, pulmonary edema and 
congenital causes such primary ciliary dyskinesia contribute to pneumonia 
Pathogenesis  
        Causative agents  commonly enter the respiratory tract but, because of  innate defense 
mechanisms, do not normally cause pneumonia. When pneumonia  occur, it usually is the 
result of an virulent microbe, a large “dose” of bacteria, and/or impaired  host defense which 
includes alveolar macrophage is capable of removing most infectious agents and multiple 
chemical mediators of inflammation, infiltration of white blood cells. 
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           In non-hospitalized people,causative agent  reach the lung by one of four routes: 
 Inhalation when an infected individual coughs or sneezes 
 Micro aspiration from the upper airways 
 Spread from contiguous infected sites 
 Hematogenous spread 
          Once the pathogen or agent enters the bronchi and bronchioles, it firmly fixes with the 
wall and causes cascade of inflammation in the host body. There are two main types of acute 
pneumonia : bronchopneumonia (with lobular topography) and lobar pneumonia (lobar 
topography). Lobar pneumonia causes  exudative inflammation of an entire pulmonary lobe. 
If not treated, lobar pneumonia evolves in four stages. Common to all stages is the 
enlargement of the affected lobe with loss of its spongy appearance 
Radiological  findings of pneumonia are airspace opacity, lobar consolidation, or 
interstitial opacities. There is usually considerable overlap. Pneumonias is a space occupying 
lesion without volume loss. Major differentiating factors between atelectasis and pneumonia 
are in pneumonic consolidation there is no volume loss ,no mediastinal or tracheal shift. Lung 
mass and consolidation are hard to differentiate since air bronchogram is seen in only 30% of 
consolidation. 
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Chest X-Ray Patterns In Different Types Of Pneumonia 
 Lobar  pattern- classical of Pneumococcal pneumonia. entire lobe appear  consolidated and 
air bronchograms are common 
 Lobular pattern(bronchopneumonia)  – often seen  Staph aureus. Multifocal, patchy, 
sometimes without air bronchograms 
 Interstitial pattern - Viral or Mycoplasma; initially shadows seen  in perihilar and can become 
confluent and/or patchy as disease progresses. There will be  no air bronchograms 
 Cavity formation :Mycobacterium tuberculosis, S. aureus, gram-negative bacilli 
 
Figure 2  Lobar pneumonia due to Streptococcus pneumoniae. Posteroanterior (A) and lateral (B) chest 
radiographs show extensive right middle lobe consolidation.  
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Figure 3: Round pneumonia. A: Anteroposterior chest radiograph shows a sharply defined rounded opacity 
in the right lower lung zone. B: Computed tomography (C T) image (5-mm collimation) demonstrates mass-
like right lower lobe consolidation 
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 Management lies on four important facts: 
 Pneumonia usually has  largely non-specific clinical features 
 It can be caused by more than 100 different pathogens and agents 
 no strong  relationship exist between specific clinical features and causative agent to allow a 
clinical diagnosis of the causative organism 
 early administration of appropriate antibiotics is very important 
No clinical study  exists to show that management  directed to a specific pathogen is 
statistically superior to empirical therapy(1). Therefore, most CAP patients are treated 
empirically .Because most cases of pneumonias are caused by bacteria, treatment usually 
involves antibiotic therapy.  
 For patients with no co morbid condition and CURB-65 Score less than or equal to 1,drugs 
includes a macrolide (azithromycin or clarithromycin) in outpatient department. In patients 
with comorbid illness such diabetes, immunosuppressive drugs and asplenia a fluroquinolone 
such moxifloxocin should be used.b-lactam antibioticplus a macrolide must be used 
 For hospitalized patients on the general wards, the IDSA/ATS guidelines recommend an 
antipneumococcal fluoroquinolone (eg, levofloxacin, moxifloxacin) or the combination of a 
beta-lactam plus a macrolide  
 For patients with severe CAP requiring intensive care unit (ICU) admission, the IDSA/ATS 
guidelines(6) recommend a beta-lactam (ceftriaxone, cefotaxime, ampicillin-sulbactam) plus 
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either intravenous azithromycin or an anti pneumococcal fluoroquinolone. If Pseudomonas is 
a concern, an antipseudomonal agent (piperacillin-tazobactam, imipenem, meropenem, or 
cefepime) PLUS an antipseudomonal fluoroquinolone (ciprofloxacin or high-dose 
levofloxacin) should be used. If MRSA is a concern, either vancomycin or linezolid should be 
added 
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MONITORING CLINICAL OUTCOME 
              In about one half of pneumonia patients, the etiologic agents are undetermined and 
if the agent is known, more definitive therapy can be initiated. Patients usually should have 
subjective improvement within 3 to 5 days of antibiotic therapy. Tachypnea, fever, and 
oxygen saturation improve within three days. Cough and fatigue, which may take 2 weeks or 
more to subside. 
      In immune competent patients who present with classical CAP (i.e., fever, chills, 
productive cough, new pulmonary infiltrate), clinical response to therapy is the most 
important determinant for further diagnostic studies. Within the first few days, persistence 
or even progression of infiltrates on chest radiographs is not unusual. Given the wide 
variation in  radiographic clearance, it remains controversial to decide when to initiate an 
invasive diagnostic work-up for non resolving or slowly resolving pulmonary infiltrates. 
Nevertheless aggressive approach is also warranted in patients who are clinically stable or 
improving when the rate of radiographic resolution is prolonged 
        During the clinical course of a CAP patient, different time interval can be selected for 
evaluation of outcome. Clinical outcome can be evaluated at the time of hospital discharge. 
At this point, the patient with improvement of infection can be classified as clinical success, 
and the patient who died during hospitalization is classified as clinical failure. Evaluation of 
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patient outcome at the time of hospital discharge is the simple way to evaluate and 
document clinical outcome. 
Based on clinical response to antibiotic therapy, the clinical outcome of CAP patients 
can be categorized by day 7 of hospitalization into patients with early clinical response (group 
1 of Figure 4), patients with late clinical response (group 2 of Figure 4), patients with early 
clinical deterioration (group 3 of Figure 4), patients with late clinical deterioration (group 4 of 
Figure 4), and patients with non resolving CAP (group 5 of Figure 4) 
 
Figure 4:Progression of CAP- 
 
In patients with a correct diagnosis, the clinical deterioration can be classified in two groups: 
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 one group of patients with deterioration owing to inappropriate antimicrobial therapy, 
 second group of patients with clinical deterioration even with appropriate antimicrobial 
therapy 
Another  reason for failure of treatment  in hospitalized patients with diagnosis of CAP is that 
the clinical diagnosis of pneumonia was incorrect .Some examples of clinical diagnosis that 
may be confused initially with CAP include obstructing bronchogenic carcinoma, lymphoma, 
intrapulmonary bleeding, bronchiolitis obliterans organizing pneumonia, and drug-induced 
pulmonary disease (e.g., amiodarone). A patient diagnosed with a noninfectious illness 
should be excluded from clinical outcome evaluation. 
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23 
 
 
 
NON RESOLVING PNEUMONIA 
           Delay in resolution of community-acquired pneumonia (CAP) is a common clinical  
outcome a pulmonologist encounter in daily clinics. Mittl and colleagues demonstrated  
that only half of patients with community acquired pneumonia have radiographic resolution 
at two weeks .Non resolving pneumonia or Slow resolving pneumonia or chronic pneumonia 
are arbitrary and not interchangeable to some extent .Some investigators focus on 
radiological abnormalities and others focus on acute/chronic and systemic abnormalities 
such as cough, malaise. 
 
Definition for slow resolving pneumonia includes: 
 less than complete clearance of radiological infiltrates in 4 weeks 
 less than 50% clearance in chest infiltrates in patients who are defervesed and improved 
symptomatically  
 non resolution of radiological infiltrates in an expected period of time based on 
presumptivediagnosis and atleast 10 days of antibiotics 
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     Another  definition endorsed by the Infectious Disease Society of North America is fairly 
vague- "a situation in which an inadequate clinical response is present despite antibiotic 
treatment". As in many things, clinical judgment is paramount – considering ongoing cough 
with sputum production, clinical status, LOW SATURATION and WBC count 
           Failure to improve after antimicrobial treatment is usually associated with the presence 
of advanced age, comorbidity, resistant pathogens, complication of pneumonic process or 
inadequate antimicrobial selection . Clearance was slower in smokers and those treated as 
outpatients .However, some noninfectious or unusual infectious diseases have a similar 
clinical, radiological and lab characteristics of CAP. This may represent a clinical  challenge to 
the physician, especially because diseases that mimic CAP usually are only considered in the 
differential diagnosis after treatment failure.  
       Wrong interpretation leads to unnecessary investigations, procedure further 
complicating the clinical course. As non resolving pneumonia or slow resolving pneumonia 
encountered  rarely as compared to more common CAP diagnosis usually warrants more 
invasive strategies. The late diagnosis often results in unwanted antibiotic therapy causing 
undue financial strain for the patient(3). 
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 OTHER DEFINITIONS FOR NON RESOLVING PNEUMONIA  
           Non resolving pneumonia is a clinical syndrome in which focal infiltrates begin with 
some clinical association of acute inflammation and despite minimum of 10 days antibiotics 
patient either dont  improve or worsen or radiographic opacities fail to resolve within 12 
weeks- J am GERIATR society 04(5) 
Treatment failure: Assessed 72 h after the beginning of the treatment, included at least one 
of the following: persistence of fever (⩾38°C) or hypothermia (<35.5°C) plus purulent 
respiratory secretions; worsening of the pulmonary infiltrate by >50%; occurrence of septic 
shock 5 or multiple organ dysfunction syndrome (MODS) 6 not present on the onset. 
Unusual infection: Isolation of an uncommon pathogen (e.g. fungus, tuberculosis) that do not 
respond to usual antimicrobial treatment. 
Mimic of pneumonia: Defined when pulmonary infiltrates and clinical symptoms of lower 
respiratory tract infection were attributed to a different diagnosis, other than pneumonia 
 
  
 
      Possible etiologies are many and include both infectious and non-infectious causes. 
Important things to consider are: 
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 Time of treatment - Patients treated less than 72 hrs should be considered as inadequate 
treatment time. 
 Infectious Causes - Consider a pathogen not covered by your treatment (e.g. tuberculosis, 
non-tuberculous mycobateria, viral or fungal infections) or a resistant organism (e.g. MRSA 
pneumonia). 
 Non-Infectious Causes - malignancy, interstitial lung disease, heart failure.  
 British Medical journal published an article enumerating causes of persistent lung lesions 
(table 1). Journal described complications such as empyema, parapneumonic effusion, lung 
abscess, host factors which includes age>60, comorbid illness, smoking, malnutrition, 
presence of drug resistant organisms such drug resistant S.pneumoniae, MRSA, unusual 
pathogens such as Atypical mycobacteria, nocardia, actinomycosis, pneumocystis 
jerovici,fungal infection such as aspergillosis, histoplasmosis, cryptococcis, coccidiodes and 
hanta virus, diseases that mimics pneumonic consolidation such lung carcinoma, bronchiolitis 
obliterans organizing pneumonia, systemic vasculitis such wengenerrs granulomatosis, 
eosinophilic pneumonia, insterstial pulmonary fibrosis, non cardiogenic pulmonary edema, 
hypersensitivity pneumonitis, radiation pneumonitis, occupational diseases,alveolar proteinosis 
and lesions with slow radiological recovery which is due to extent of pneumonic consolidation 
such as extensive lobar pneumonia and bilateral pneumonia and level of  bacteremia. History 
of travel is also very important in excluding causes pertaining to that region. Patients immune 
status should also be assessed since opportunistic infection are more common. History 
regarding rearing of pet animal such as dogs and cat should be enquired to rule out psittacosis. 
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Table 1: causes of non-resolving pneumonia 
 
DIAGNOSTIC DILEMMAS      
         The diagnosis of mimics may be delayed for FOLLOWING reasons:  
1. Wrong clinical assessment (fever, cough, respiratory secretion and pulmonary infiltrates) 
2. Empirical therapy lacking broad spectrum coverage 
3. Obtaining late investigation 
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4. Lack of knowledge of pneumonia mimics 
5. Not using invasive diagnostic modalities 
                  A good detail clinical history helps to clinch the diagnosis .diseases like tuberculosis 
shows endemicity and geographical characteristics. Some diseases occur affecting two or 
more system in our body along with lung pathology. Patient ‘s personal history such as 
smoking, alcohol consumption and occupation should be noted.        
Investigations available: 
1. Blood testing 
2. Serological testing 
3. Culture methods 
4. Radiological modalities 
5. Bronchoscopy 
6. USG or CT guided aspirations and biopsy 
       There cannot be a single algorithm  to find out all possible etiologies in non resolving 
pneumonia. All these modalities should be selected based on case preference in evaluating 
non resolving pneumonia taking into account patient’s clinical and economical background. 
Cultures methods should be repeated since the culture performed initially and after a month 
will show marked variation. Microbes with prolong generation time and resistant pathogens 
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are not seen in initial culture plates. Patient’s immune status showed be taken in order the 
test. In HIV patientsand immune compromised individuals atypical microbes are common. 
     CT chest and chest X-ray should be repeated to find out the lesion clearance, worsening 
then and there. For pneumonia mimics and suspected malignancy invasive procedures such 
bronchial biopsies using FOB,USG guided FNAC or biopsy are warranted. 
        In conclusion, unusual infectious and noninfectious diseases should always suspected 
and included in the differential diagnosis of patients with presumptive diagnosis of 
pneumonia  but who present with treatment failure, specially those young and previous 
healthy patients. The first step toward those diagnostics is to constantly be aware of their 
possible presence. 
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ULTRASOUND CHEST 
          Diagnostic ultrasonography is the only clinical imaging technology currently in use that 
does not depend on electromagneticradiation. This modality is based on the propertiesof 
sound waves, and hence the mechanical and acoustic properties of tissues. Air is a poor 
medium for sound transmission. As lung contains air, ultrasound of the lung may seem 
counterintuitive. The interface between chest wall and normal lung with different acoustic 
densities reflects most of the ultrasound(15) waves, preventing a direct examination of an 
otherwise healthy lung. 
        In pathological conditions such as tumor invasion, consolidation or atelectasis, the alveoli 
are replaced with more dense tissue allowing better sound conduction. When the pleural 
space is occupied with fluid or the consolidated lung reaches the chest wall, it opens an 
acoustic window permitting ultrasound examination of the lung. 
       Regarding diagnostic ultrasound equipment, ceramic crystals in the transducer deform 
and vibrate when electronically stimulated to produce the sound pulses. Echoes that return 
to the transducer distort these crystal elements and produce an electric pulse, which is 
processed into an image. 
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Ultrasound  in the hands of  the Pulmonologist: 
            Diagnostic ultrasonography is a very valuable tool for imaging the chest because it 
causes no clinically significant biological effects, is a real-time examination and has multi 
planar imaging capability. In real time one can focus the study on a painful or palpable area. 
This modality of ultrasonography can be portable, very significant for the ICU and emergency 
room. Trans thoracic ultrasound can be used to evaluate peripherally based lung lesion, 
pleural diseases. 
 
 The maximum visualization of the lung and pleural space is done by scanning along the 
intercostals spaces during quiet respiration for normal lung movement; and in suspended 
respiration when a lesion can be studied in detail.. Ultrasound is used as guidance for 
interventions such as biopsies or intercostals chest drains or pleural fluid taps .The high 
degree of spatial resolution in B-mode and the flow imaging in the Doppler mode help 
diagnose lesions in the thoracic wall The modality of ultrasound can be used to distinguish a 
chest wall mass from a breast mass and can be used to guide a biopsy needle into the tissue . 
 
 The skin of the thoracic wall appears on ultrasound images as an echogenic layer 1–
3mm thick. Subcutaneous fat is just under the skin. The large muscles that comprise the 
middle layer of the chest wall are: the pectoralis,  serratus,  latissimus dorsi and trapezius. On 
ultrasound images skeletal muscle appears as uniform with multiple echogenic striae over a 
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hypoechoic background on longitudinal scans, and multiple echogenic dots over a hypoechoic 
background on transverse images. Ultrasound has been used to illustrate the extent of an 
anomaly such as the absence of muscle in Poland’s syndrome. The deepest layer of the 
thoracic wall is comprised of ribs , the intercostal musculature, and the parietal and visceral 
layers of the pleura. 
              
Principles of Thoracic Ultrasound 
      Lung patterns during examination are mostly dynamic and the thoracic ultrasound 
examination is largely based on the analysis of artifacts . Familiarity with various common 
artifacts and adequate technical skills are the basic requirements for thoracic ultrasound. 
The examination using USG is dependent on the skills of the individual operator and 
the orientation of the probe. So, reproducibility of images is not as precise as with other 
imaging such as CT. An optimal image acquisition depends on the choice and placement of 
the appropriate probe with an adequate preset at the right spot at an optimal angle with the 
patient in the best possible position. Good thoracic ultrasound examination consists of not 
just the acquisition of static images but analysis of the dynamic sono morphological changes 
associated with probe positioning or respiratory movement(17) 
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Echogenicity 
Ultrasound images are displayed on a gray scale. The strongest echo appears white while it is 
black when no sound wave is reflected from the organs. Depending on thereflected wave 
amplitude, the following terms are used to define chogenicity. When no sound wave is 
reflected and the image appears black it is anechoic as in pleural effusion.It is isoechoic when 
the echoes are of comparable amplitude with the surrounding tissue as with kidneys or 
spleen. It is hyperechoic when echoes are stronger than the surrounding tissue as in 
diaphragm, and hypoechoic when it is weaker than that from the surrounding tissue 
Description of Probe 
    Penetration lung tissue  decreases as frequency of  the probe increases. Superficial organs 
are better visualized with higher frequency and deeper structures with lower frequency 
transducers. The gain and the power of the ultrasound need to be adjusted to obtain an 
adequate image. Most ultrasound equipments have preset modes for better imaging of 
specific organs of the body. For superficial imaging, a preset for the thyroid gland is useful. 
Otherwise most of the thoracic structures  may be examined with abdominal preset. The size 
of the probe is vital in real-time interventional procedures. A smaller probe will leave more 
room for needle insertion during real-time vascular access, thoracentesis, tube thoracostomy 
or percutaneous biopsy. There areprimarily three types of transducers used in thoracic 
imaging, e.g. linear array, curvilinear array and a phased array.  
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Linear array transducers(fig 5a) have piezoelectric crystals arranged in a linear sequence on 
the transducer head . Parallel pulses are generated forming a line of sight perpendicular to 
the transducer face with a large footprint (part of transducer in contact with body surface). It 
produces a rectangular display. A linear array 7.5- to 10-MHztransducer with a thyroid preset 
is best to visualize superficial structures of the neck. This is also useful for vascular access or 
to determine pleural thickening, pleural masses or subpleural parenchymal lesions of lung. 
These high-frequency transducers provide an excellent high-resolution image of superficial 
structures but are not ideal for deeper tissue examination. 
The curved array transducers (fig 5b) consist of linear arrays shaped into convex curves that 
produce a large field of view with a large footprint . These provide a pie-shaped image and 
are helpful to examine large pleural effusion,lung or abdominal structures or to view the lung 
from an abdominal approach. In the phased array transducers, crystals located on the 
transducer head are pulsed as a group and the direction of the beam is continually changed 
in phases producing a pie shaped  image with a smaller footprint .The benefit is a relatively 
smaller transducer with a large field of view at depth. A 2- to 5-MHz-phased array or a sector 
probe is good to visualize deeper structures such as atelectatic lung, complicated pleural 
effusion or heart through the intercostals space. They are also useful to visualize the pleural 
space from an abdominal approach through the liver. 
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Figure 5 :curvilinear probe and linear probe 
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Position of the Patient and Relationship with Other Organs 
          In the ultrasound nomenclature, a popular term used is the earth-sky axis. The thoracic 
organs are composed of water and air. Air rises and the water descends following the rules of 
gravity. Intrathoracic organs and pleural fluid shift with different patient positions. Successful 
examination depends on appropriate understanding of the anatomy in relation to patient 
position during image acquisition 
The lymph nodes or tumors of the anterior mediastinum that are not in contact with 
the chest wall in supine position may come against the chest wall when the patient is turned 
to a slightly prone left or right lateral decubitus position. A sitting position is ideal to localize 
very small pleural effusion, as most of the fluid is then collected in the costodiaphragmatic  
recess. The probe may need to be held close to the surface of the bed to locate pleural fluid 
in a supine patient in the ICU. Masses or lymph nodes in supraclavicular or the anterior 
mediastinum may be best visualized by turning the patient’s head to the extreme right or left 
or in flexion or extension. Pleural space can be visualized better from a posterior approach in 
a sitting patient with the hand placed on the opposite shoulder or above the head. 
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Orientation of Transducers 
The interpretation of trans thoracic USG images is based on the skill of the operator  to 
correlate the obtained images virtually with the patient anatomy. Although ultrasound 
provides a 2-dimensional image, by sliding or tilting the transducer or by observing 
respiratory movement, a 3-dimensional dynamic image may be reconstructed in the mind. 
Being able to see the 3-dimensional image of the pathological changes is a key factor in 
image interpretation. Depending on the location of the target organ, patient position, clinical 
complaints, chest radiograph or CT images, the examiner tries to orient the transducer to the 
best possible site. However, this requires experience. Each transducer is marked with a probe 
indicator, signifying the direction of examination that corresponds to a marker on the display 
screen. Usually this marker is placed on the left upper corner of the display screen; however, 
most current ultrasound units allow customization of the screen. 
The probe indicator of the transducer is placed in the cephalad direction during 
sagittal scanning of the chest. The probe indicator should be placed as much cephalad as 
possible when scanning through the inter costal window along the rib axis. Intrathoracic 
structures may be visualized better by holding the probe along the longitudinal or transverse 
axis over the rib spaces. It may take several attempts to find the best position and the correct 
angle to inspect a target structure. Anatomic landmarks are of assistance especially before 
any invasive procedure. Pleural surface on the right side is limited by the liver and the 
diaphragm, and on the left by the spleen with the diaphragm. The demonstration of kidneys 
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on either side indicates structures below the diaphragm. The sono morphological image of an 
empyema is very similar to a full stomach. Identification of these organs will assure a safe 
procedure and prevent needle puncture of liver, spleen or a full stomach. 
Technical Skills 
Good hand control is essential for successful scanning. By holding the probe 
comfortably, visualization can be maximized with a gentle rotating and rocking movement of 
the transducer. By sliding the transducer slowly over different rib spaces, a better window for 
visualization may be found.  Using the thenar eminence to stabilize the hand against the 
chest wall during examination will prevent any unintentional sliding of the probe. 
PROCEDURE: 
It is important to analyse the the patient's chest x-ray or  CT  to finalise the area of interest 
before doing USG. Maximum visualization of the lung and pleural space is achieved by 
scanning along the intercostal spaces. USG must be done when is the patient lies quiet and 
respire normally(FIGURE 6).  Sonographic views of the different areas depend upon  where 
you place the probe. 
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Figure 6 : Patient position while doing usg. 
 
Figure 7 : A peripheral lung lesion is shown schematically without (top) and with (bottom) pleural contact. 
The corresponding sonar images recorded with a sector scanner are shown on the right. Only thelesion with 
pleural contact is visible on USG. Note that the acoustic window is too narrow to demonstrate the whole 
circumference of the lesion.  
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Peripherally based lung mass or consolidation can  detectable by means of USG, 
although the extent of disease appears smaller at US than on chest radiographs.the lung 
consolidation appears diffusely echogenic, similar to the liver seen in abdominal ultrasound 
(Figure 7). 
ULTRASOUND CHEST SHOWING AirBronchogram 
 
Figure 8:USG chest showing hyperechoic lesion with air bronchogram 
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USG CHEST SHOWING LUNG TUMOUR 
 
USG CHEST SHOWING CYST 
 
FIGURE 9: USG SHOWING HYPOECHOIC LESION DENOTING CYST 
 
 
 
Figure 10 :    USG CHEST shows consolidated lung appearing  isoechoic to the liver. Air bronchogram is seen 
as multiple  echogenic images inside the lung
 
 
 
Clinical Applications of Ultrasound
 Ultrasound technology ranging from bulky machines to ultraportable pocket size 
equipments are now available. Thoracic 
 
Pneumothorax 
 Air localized within the pleural cavity collects in the nondependent part and is best 
identified in the supine position with the probe held perpendicularly on the anterior 
chestwall. A pneumothorax is usually diagnosed by the absence of sea shore sign and 
presence of bar code sign. M-mode is of additional help. Operator experience is crucial to 
analyze these artifacts. 
42 
 
 
USG is used to identify following pathology:
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Pneumonia 
Consolidated lung in contact with chest wall or contained in pleural effusion may appear as 
echogenic. Similar findingsmay be seen with pulmonary hemorrhage, 
bronchoalveolarcarcinoma or a lung infarct. Branching hyperechoic structures representing 
air bronchogram may be seen. Atelectatic lung is usually echogenic without any air 
bronchogram. 
 
Primary or Metastatic Lung Cancer 
Peripheral lung masses close to the pleura appear hypoechoic;however, it may become 
echogenic with bleeding. Diaphragmatic involvement can be detected through liver with an 
abdominal approach or with a transthoracic  approach when pleural effusion is present 
 
Chest Wall and lymph nodes 
Soft tissue invasion of the chest wall by a primary lung cancer or chest wall tumor is easily 
detected. Ultrasound provides a better image of the Pancoast tumor than CT .Only MRI offers 
a good image of this complex anatomical location. Comparison of findings with the healthy 
normal  side may be a clue to diagnosis. Bony invasion of tumors like plasmocytoma appear 
as hypoechoic lesions. The fracture of ribs or clavicle can be identified. Benign or  malignant 
lymph nodes can be differentiated based on the consistency  or vascularity. 
 
 
44 
 
 
Ultrasound-Guided FNAC  
  Subpleural peripheral lung, pleural-based or chest wall masses  can be safely aspirated with 
ultrasound guidance.This technique largely depends on obtaining an image through an 
adequate acoustic window. A lung abscess reaching the chest wall may be percutaneously 
drained with ultrasound guidance. 
 
 
To  conclude USG is as effective as CT for guidance of transthoracic needle aspiration  of 
peripherally based lung lesion and offers a number of advantages. In  USG  is useful 
diagnostic tool for critically ill patients with chest disease. 
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FINE NEEDLE ASPIRATION CYTOLOGY-LUNG 
Non resolving or slowly resolving pulmonary pathology is often diagnosed using  fine-
needle  aspiration  cytology  technique .   Appreciation of  FNAC for lung lesions has been 
rapid due to the difficulty in diagnosing peripherally based lung mass or consolidation. 
sensitivity of FNAC and simpler ways  of treating the complications associated with the 
procedure has made FNAC an important diagnostic modalities 
Infections  such as tuberculosis and other benign lesions may be proven by FNAC but 
the main purpose still remains the diagnosis of suspected malignancy of lung parenchyma 
and pleura. All pulmonary lesions including  hilar lesions are now routinely and safely 
diagnosed using FNAC under USG or CT Guided. FNAC of palpable  lymph nodes can also be 
done.     
    
 FNAC IN DIAGNOSIS of LUNG INFECTIONS:  
 FNAC is very useful in diagnosing tuberculous lesion which is endemic in our country. 
FNAC of lung parenchyma infected with Mycobacteria typically shows on caseating  
granulomas (figure 11)which will guide in further treatment. 
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  
Figure 11: confluent granulomas are surrounded by dark blue lymphoid cells. At the center of the confluent 
granulomas is a pink zone of necrosis 
A suspicious tuberculous infection with (pyrexia, night sweats, contact with tb patient) 
coupled with positive aspirate, sputum AFB adds to the diagnosis of TB. 
 Actinomycosis infection usually seen in immunocompetent patients with respiratory 
disorders, poor oral hygiene, chronic alcoholic .It iscaused by actinomyces species, especially 
Actinomyces israelii. Typical CT findings are reported as central areas of low attenuation 
within the consolidation. FNAC  (Figure 12) helps  in diagnosing the lesion. FNAC has been 
proven to be a simple, safe, and effective diagnostic technique that reduces the number of 
unnecessary resections(36). 
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Figure 12: ‘Sulphur granules’ are crushed between slides and stained by gram stain and examined. The 
granules are, in fact, bacterial colonies and will be found to consist of a dense network of thin Gram positive 
filaments, surrounded by a peripheral zone of swollen radiating club shaped structures, presenting a sun ray 
appearance 
 
 
 In non resolving  lung abscess caused mostly by aerobic and anaerobic bacteria,FNAC has a 
role in diagnosis and therapy. Common bacilli that includes S pneumonia mainly leads to 
acute inflammation characterized by sheets of polymorphonuclear neutrophils ,histiocytes, 
nuclear debris and necrosis (figure 14)which results in tissue destruction causing lung 
abscesses 
 
 
48 
 
 
Figure 13: macroscopically pus is aspirated. 
 
Figure 14: Sheets of acute inflammatory cells in suppurative inflammation 
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 Incidence of fungal infections risen over the last two decades because of of emergence of HIV 
infection and solid organ transplant . Aspergillus, Cryptococcus and Candida are the most 
common fungal infections. On microscopic examination, the hyphae of the Aspergillus 
species are septate with regular, progressive and dichotomous branching usually at acute 
angles (45º angle) from the parent hyphae(figure 15). 
 
 
Figure 15:  A long septate hyphae with parallel cell walls of aspergillus in a necrotic background 
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FNAC IN BENIGN LESIONS: 
 Sarcoidosis is a disease of unknown aetiology that can be characterised by the histological 
hallmark of non-caseating granulomas. Most patients present with the classic combination of 
bilateral hilar lymphadenopathy, parenchymal disease of the lung, and eye or skin lesions 
 
 
Figure 16: shows characteristic noncaseating granulomas with many giant cells. 
 Thymoma(figure 17) is the  most common anterior mediastinal tumor. FNAC has a major role 
in diagnosis of thymoma and other anterior mediastinal tumors because management varies. 
 
 
51 
 
 
Figure 17 : Biphasic pattern of cohesive epithelial cells in a background of lymphoid cells 
 Schwannoma(figure 18) is the most common thoracic paravertebral mass lesion in the adult. 
Schwannomas appear as well-circumscribed, round masses that are of homogenous soft-
tissue density on plain CT images. 
 
Figure 18 : Rosette like structure with central hyalinized area 
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FNAC IN PREMALIGNANT AND MALIGNANT LESIONS: 
        FNAC is highly cost effective ,first line investigative technique in diagnosing premalignant 
and malignant lung lesions nowadays .a good sample and a well informed pathologist is the 
key for diagnosis 
 
 In premalignant  and  carcinoma in situ case such as squamous dysplasia(figure 19) ,FNAC 
assist in period review of progression of lesion.Repeated FNAC aid in diagnosis. 
 
Figure 19: cytology of squamous dysplasia resembles squamous metaplasia with nuclear atypia (Papanicolaou 
stain). 
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Figure 18: Undifferentiated carcinoma – Highly pleomorphic,undifferentiated cells in sheets 
 
 Majority of lung malignancy  is diagnosed in advanced stages, where cytology or small biopsy 
material is the only form of tissue diagnosis, thus placing cytology, especially fine needle 
aspiration biopsy in the front line for management of lung cancer patients. Published reports 
reveal that the sensitivity of FNAC in diagnosis of lung malignancy  ranges from 55- 90%  
whereas specificity is close to 100%. In nearly all these studies, the overall positive predictive 
value is nearly 99%. 
 
      Lung cancer histological subtypes that are morphologically recognizable on cytology 
specimens are adenocarcinoma, squamous cell carcinoma,small cell cell carcinoma and large 
cell carcinoma. 
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SMALL CELL CARCINOMA: 
 
Figure 20: diffuse proliferation of small to intermediate sized cells (arrow) generally ith very scant cytoplasm 
and round to oval hyperchromatic nuclei. The tumor cells are generally larger than small lymphocytes 
SQUAMOUS CELL CARCINOMA: 
 
Figure 21: neoplastic cells with abundant pale eosinophilic cytoplasm and a surrounding infiltrate of 
inflammatory cells which can also be seen among the tumor cells in the fine needle aspirate specimen 
LARGE CELL CARCINOMA : 
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figure 22: cell size—larger nuclear:cytoplasmic ratio—lower nuclear chromatin—coarser nucleoli--present in 
many cells. certain large cell carcinomas have a nesting or trabecular pattern, often with rosettes 
 
 
ADENOCARCINOMA: 
 
FIgure 23: Adenocarcinoma aspirates include architectural features in the cell sheets,  
such as gland acini or an anatomical border. 
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MESOTHELIOMA:
 
Figure 4: Smears consisted of dispersed populations of polygonal cells with cellular and  
nuclear pleomorphism along with spindle-shaped cells. Increased mitotic activity and  
features of necrosis were evident in the smears(17) 
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REVIEW OF LITERATURE 
              Many clinical studies and investigations had been conducted to study the usefulness 
of USG in the diagnosis of pneumonia. Most important study which brought USG guided 
FNAC in identifying lung pathology was done by group of histopathologist and interventional 
radiologists in Rajshahi medical college in Bangladesh.USG guided FNAC was done for 127 
Patients whose lesion were very well visualized by ultrasound. The study was conducted for 2 
years. This study was published in December 2007 in journal of teachers association,Rajshahi. 
Main objective of the study was to study diagnostic accuracy and cost effectiveness of 
ultrasound guided FNAC in diagnosing intra thoracic masses. 
          Nahar begum et al(24) subjected 127 cases (which was the large sample study ) of 
thoracic masses to USG OR CT GUIDED FNAC. Smaller lesions,deeply blocated 
ones,mediastinal or juxta hilar lesions which were not visualised sonographically ,FNAC was 
done using CT GUIDANCE. In 106 cases of USG –GUIDED FNAC, conclusive cytodiagnosis was 
made in  98 cases resulting in diagnostic accuracy of 93.8%.No diagnosis was obtained in 6 
cases. Complication such as pneumothorax or hemoptysis were noted in larger lesions and 
deeply seated lesions. Mild to moderate pneumothorax 
developed in  7 (6.6%) cases and subsided with conservative treatment. One died within few 
hours of FNAC.4(3.8%) patients complained of hemoptysis post procedure which settled 
spontaneously.3 patients(2.8%) had hemorrhage which was managed conservatively. FINAL 
OUTCOME OF THE STUDY was USG GUIDED FNAC HAS SENSITIVITY 91.2% AND 
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SPECIFICITY 100%. FOR DIGNOSIS OF MALIGNANT LESION AND FOR BENIGN 
LESION DIAGNOSIS SENSITIVITY WAS 68% AND SPECIFICITY 100% .Prevalence of 
malignancy was 72.3%(n=76)  and tuberculosis 11(n=11).The study finally concluded that 
ULTRASOUND guided FNAC is a very valuable diagnostic modality for early diagnosis 
which will enable expeditious treatment. More so in poor economic status of the patient who 
are unable to provide money for CT CHEST ,USG GUIDED FNAC HAS BEEN SHOWN TO 
BE A COST EFFECTIVE METHOD OF DIAGNOSIS. 
 
         The study which was conducted by interventional radiologist compared their data with 
studies done previously since 1988.These studies showed varied sensitivity ranging from 81 to 
98 % and complication rate including pneumothorax,haemorrhage and hemoptysis ranginging 
from 42.7% to 1.1 %.All the studies were undertaken by radiologist who had hands on training 
in handling ULTRA SOUND. 
        From series of study published,MOHAMMED(33) et al series had an 
excellent diagnostic accuracy of 97%(out of 184 cases selected) and pneumothorax 
incidence was 1.1%.But incidence of hemoptysis was (5.4%).Following this series 
GOULIAMOUS(28) et al had a sensitivity of 98.4%,and pneumothorax incidence 
3.1%.STANLEY et al who had largest series of patients who underwent USG guided 
FNAC had sensitivity of 96.6% but the incidence of pneumothorax was huge 29%. 
        All these studies were done exclusively done by WELL TRAINED QUALIFIED 
RADIOLOGIST who handle ULTRASOUND day and night.Treating physician or the 
Pulmonologist were not involved in the diagnosis  
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SUMMARY OF RESULTS OF REPORTED SERIES 
References No. of Cases Diagnostic 
accuracy 
 
Pneumothorax Complication 
Bleeding 
Hemoptysis 
Stanley et al. 1988 [12] 
 
458 96.6% 133(29%) - 5 (1.1%) 
Vansonnenbergetal 1988[4] 
 
150 82.7% 64 (42.7%) - 25 (3.3%) 
Haramati et al 1995 [13] 
 
32 81% 3 (9.4%) - - 
Santambrogioetal 1997 [14] 
 
110 81% 3 (9.4%) - - 
Gouliamos et al 2000 [15] 
 
64 98.4% 2 (3.1%) 1(1.6%) - 
Mohammad et al 2001 [16] 
 
184 97% 2 (1.1%) - 10 (5.4%) 
Gupta et al 2002 [17] 
 
37 91% 1 (2.7%) 1 (2.7%) - 
J P Sing et al 2004 [18] 
 
34 85.3% 4 (11.8%) 4 (11.8%) 1 (2.9%) 
 
             Another study which was published in THORAX 2002 by PAN CHYR YANG et al 
,national Taiwan university hospital .According to this study diagnostic accuracy of USG 
GUIDED FNAC WAS ONLY 30%  whereas USG guided BIOPSY  was 57%.Combination of 
both the test yielded a diagnostic accuracy of 63%.Commonest cause identified for non 
resolving pneumonia in that series were fungal pneumonia, tuberculosis and bronchoalveolar 
carcinoma. Two patients had complication, -pneumothorax and hemoptysis. 
  
    
Qian-Jing Hu et al of West China Hospital of Sichuan university analysed studies  
published in pubmed,Ebase and Cochrane analysis. Results obtained from 9 different  studies 
involving 1080  patients on chest USG as diagnostic tool were pooled using a bivariate meta 
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analysis. SUMMARY ESTIMATES IN THOSE STUDIES SHOWED SENSITIVITY -0.97 AND 
SPECIFICITY 0.94.POSITIVE LIKELIHOOD RATIO 15.62(95%) NEGATIVE LIKELIHOOD RATIO  
0.03(95%). Accuracy is measured by the area under the ROC curve  which was  O.99.THIS 
META ANALYSIS showed lung ultrasound is capable of diagnosing pneumonia with high 
accuracy and is a safe alternative test to CT chest and bronchoscopy. But demerit of this 
analysis was that this study didn’t come up with  percentage of pneumothorax and other 
complication. Data lacking in this analysis was rate of complication such as pneumothorax, 
bleeding and haemorrhage which occurs during the diagnostic procedure. 
           Another  study conducted by HAYDER et al in college of medicine ,university of Babylon 
,Iraq assessed the value and safety of USG guided lung FNAC in diagnosis of bonchogenic 
carcinoma. Out of 75 cases evaluated by USG guided FNAC, 57 cases were diagnosed to 
have bronchogenic carcinoma. There was no controversy between final diagnosis  and FNAC 
results except in one case where gold standard biopsy showed TB infection and FNAC showed 
small cell carcinoma (false positive) in remaining 18 cases, 
 6 cases were benign lesions which later investigation showed malignancy(false negative 
results) 4 cases were slowly resolving pneumonia and 3 cases were tuberculous etiology  
and 5 cases left out 
           Shivani kalhan et al(21)in army college of medical science,sarawathi instititute of 
medical sciences Uttarpradesh  done an comparative study of USG guided FNAC and CT 
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guided FNAC in lung mass. Study was conducted on 120 patients. Only those cases in which 
sonographic guidance was not possible were taken up for CT guided FNAC. CT had  
a sensitivity of 93.2% and specificity of 100%. For USG guidance, the same was 91.3% and 
100%  respectively finally concluding that precision of both ct and USG guidance is 
comparable. The demerits of this study was that complications were not studied. More over 
USG and CT guided FNAC were done by pathologist under the guidance of radiologist. 
   Another study conducted in Tirvandrum medical college pulmonary Medicine   
department by Jeyaprakash et al(10) concluded that out of 70 patients included in the study.    
Tuberculosis was the commonest etiology of non resolving pneumonia (35.7%), followed by 
malignancy (27.1%), Bronchiectasis (8.6%), and Resistance to  antibiotics(14.3%).In this study 
all investigation modalities were employed including  USG  chest. 
 
         The study published by MANS MADAN et al, department of pathology, Giansagar 
medical college AMRISTAR in Turkish journal of pathology stressed the accuracy of FINE 
NEEDLE ASPIRATION CYTOLOGY in diagnosis of thoracioc lesions. This study was done for one 
year.40 patients were included in the study out of which 24 cases (60%) had malignancy .In 
this study imaging modality was CT 
Bhupendra kumar jain et al conducted a study which was published in Asian journal of 
medical sciences comparing the efficacy of FOB and CT guided FNAC IN DIAGNOSING NON 
RESOLVING PNEUMONIA. Out of 65 cases 53 patient were diagnosed with the help of FOB 
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WITH SENSITIVITY 81%.OUT OT 12 PATIENT WHO UNDERWENT CT  GUIDED FNAC ,11 WERE 
DIAGNOSED THE CAUSE WITH SENSITIVITY 91%.63 cases (96.9%) were diagnosed by using 
both FOB and CT guided FNAC.in this study commonest cause for non resolving pneumonia 
was pyogenic infection(37%) followed tuberculosis 29.2% and carcinoma(23%).out of 12 
patients who underwent ct guided FNAC 1 patient had pneumothorax and 1 patient had 
hemoptysis. 
            Simon Finch et al from  Tayside Respiratory Research Group, University of Dundee, 
Scotland published an article about etiologies of non resolving pneumonia. According to his 
study most common causes are atypical pathogens such mycobacteria. According to them 
non-infectious causes are common than infectious disorders but may still affect >20% of 
patients with non resolving pneumonia.  
        
 
     With all these studies and results, I undertook my present study to test the diagnostic 
accuracy of ULTRASOUND  GUIDED FNAC  in the hands of treating PULMONOLOGISTS in 
diagnosing non resolving pneumonia and finding out the yield and causes of non resolving 
pneumonia. 
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MATIERIALS AND METHODS 
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STUDY TITLE: 
      YIELD  OF  ULTRASOUND  GUIDED  FNAC  IN  NON  RESOLVING  LUNG 
CONSOLIDATION  IN  TEACHING  MEDICAL   COLLEGE HOSPITAL ,TIRUNELVELI  
Aim:  
 This  study aimed to find out the yield of ULTRASOUND GUIDED  FNAC IN NON 
RESOLVING CONSOLIDATION. Sub study includes comparing the yield of USG guided FNAC 
and Bonchoscopy in finding out the diagnosis of non resolving pneumonia 
 
Settings and Design: 
          This is  Prospective  observational  study conducted in a the department of chest  
medicine ,Tirunelveli government medical college hospital over a period spanning from may 
2014 to august 2015(about 1 year and 8 months). 
 
 Materials and Methods: 
        After getting a due consent from medical institution’s ethics committee study was 
started with the guidance from department of pathology and radiology. Inclusion and 
exclusion criteria were pre fixed and patients were selected accordingly. All patients received 
an empirical course of antibiotics as suggested by American Thoracic Society guidelines. 
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INCLUSION CRITERIA   
1. PATIENTS WHO FULFILL THE DIAGNOSIS OF NON-RESOLVING PNEUMONIA    (NO  
RADIOLOGICAL RESOLUTION AFTER 4 WEEKS  OF ANTIBIOTICS) 
2. SPUTUM CULTURE NEGATIVE AND SPUTUM FOR AFB NEGATIVE 
3. HIGH CLINICAL AND RADIOLOGICAL  SUSPICION OF LUNG CARCINOMA  
 
EXCLUSION CRITERIA 
 
1. KNOWN PATIENTS OF LUNG CANCER  
2. SPUTUM-POSITIVE PULMONARY TUBERCULOSIS 
3. PATIENTS HAVING VERY POOR GENERAL CONDITION, VERY SEVERE BREATHLESSNESS, 
RECENT 
 HISTORY OF MYOCARDIAL INFARCTION. 
4. POSITIVE TEST RESULT FOR HUMAN IMMUNODEFICIENCY VIRUS(HIV) INFECTION 
5. UNWILLING PATIENTS WERE OMITTED FROM OUR STUDY. 
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STUDY PROTOCOL: 
         Clinical, radiological and laboratory tests were performed before initiating empirical 
antibiotics, and after they fail to improve after antibiotic therapy. A STRUCTURED PROFORMA 
was  used. Patients age, sex and smoking history if present were noted. Prior investigations, 
sputum for AFB, sputum culture report and HIV reports were noted down .proper consent 
was obtained from the patients after procedure was explained in their local language and 
consent form duly signed in their local language. All patients who were included in the study 
were hospitalized for a day to look for complication such pneumothorax and bleeding. Chest 
x-ray were done 6 hours after the  procedure. Standard operating procedure for managing 
PNEUMOTHORAX was  fixed according to British Thoracic society guidelines. Investigations 
done in this study after labeling the patient as patient with non resolving pneumonia  were 
ultrasound guided FNAC done with 21gauge needle and bronchoscopic wash culture and 
cytology and biopsy if warranted. 
 
INSTRUMENTATION: 
       ULTRASOUND LT200 MODEL WITH CURVILINEAR PROBE WITH FREQUENCY OF 3.5 MHZ 
TO 5MHZ WAS USED BY THE PULMONOGIST and chest medicine postgraduates who were 
trained in handling ultrasound.10 ml syringe with 21 gauge needle was used for FNA and 
smear slides were air dried and sent to pathology department. Bronchoscopy was done using 
Olympus fibre optic bronchoscope and specimen were collected under standard norms and 
sent for culture and histopathology. 
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RESULTS 
  
 
 
 
SAMPLE SIZE: 
      Sixty two (N = 62) patients who filled the study 
criteria were selected for the study
GENDER : 
    Out of 62 patients ,majority were males 89%(n=55)
25) 
Figure 25:Gender distribution 
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criteria BOTH inclusion and exclusion 
. 
 and females were only 11%(n=7)
 
(figure 
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AGE DISTRIBUTION:  
        3%(n=2) patients were between(21-30years),5%(n=3) were between (31-
years),16%(n=10) were between 41-50 years ,32% (n=20) were between 51-60 
years,34%(n=21) were between 61-70years which was majority age group and 10%(n=6) 
were between 71-80years age group(figure 26) 
 
Figure 26:Age distribution 
3%
5%
16%
32%
34%
10%
0%
5%
10%
15%
20%
25%
30%
35%
40%
21-30 31-40 41-50 51-60 61-70 71-80
P
e
rc
e
n
ta
ge
Age in Years
AGE DISTRIBUTION
 
 
70 
 
 
CT PATTERN IN THE STUDY 
     Computerised tomography of patients with non resolving pneumonia included varied 
distribution. Consolidations that were adjacent to chest wall were the ones selected for 
ultrasound guided FNAC. Majority of the patients with non resolving pneumonia had 
lesions(table 2) in right upper lobe29% (n=18) followed by lesion distributed in right lower 
lobe 24%(n=15).Non resolving consolidation was seen in equal proportion in right middle 
lobe and left lower lobe 18%(n=11). Consolidation were seen in 8%(n=5) of left upper lobe. 
Multi lobar distribution of consolidation were seen in 3%(n=2). 
Table 2: CT PATTERN 
CT PATTERN  
N – 62 
 
% 
Right upper lobe 18 29% 
Right lower lobe 15 24% 
Left upper lobe 5 8% 
Multilobar 2 3% 
Left lower lobe 11 18% 
Right middle lobe 11 18% 
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YIELD OBTAINED BY FNAC 
         In 59 patients out of 62 with undiagnosed non resolving consolidation .USG guided 
FNAC established the etiology. Percentage of yield was staggering 95.2%. In 3 cases results 
were inconclusive. Percentage of NO YIELD was 4.8%.(Table 3) 
Table 3: YIELD OF USG GUIDED FNAC 
YIELD OBTAINED YIELD NOT OBTAINED 
 
59 (95.2%) 
 
3 (4.8%) 
 
DISTRIBUTION OF CASES 
Incidence Of smear positive for malignancy was 76%(n=47).incidence of granulomatous 
lesion was 8% (n=5).incidence of inflammatory smear was 4%(n=3).no of smear with infective 
material was 3%(n=2).incidence of dysplasia and benign lesions were 
3%(n=2),4%(n=3).majority of lesions diagnosed were carcinoma in my study followed by 
granulomatous lesions(Table 4). 
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Table 4: Etiology of non resolving pneumonia in my study 
Diagnosis Number Percentage 
Positive for malignancy 47 76% 
Granulomatous Lesion 5 8% 
Inflammatory 3 4% 
Infective  2 3% 
Dysplasia 2 3% 
Benign Lesion 3 4% 
Total 62 100% 
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CYTOLOGICAL TYPING OF MALIGNANT LESIONS : 
           Majority of patients with non resolving pneumonia in my study were diagnosed to have 
malignancy by USG guided FNAC. Most common malignancy diagnosed was non small cell 
carcinoma. Incidence was 36%(n=17)(table 5). Next in this series was squamous cell 
carcinoma with the incidence of 28%(n=13). Adenocarcinoma was seen in 15% (n=7) of 
cases.6.3% (n=3) of cases were large cell carcinoma. Incidence of undifferentiated carcinoma 
and pleural tumours were 6. 3%(n=3) respectively. Least common malignancy  diagnosed in 
my study was small cell carcinoma 2%(n=1). 
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Table 5 :Cytological types of malignancy in my study 
TYPING NUMBER PERCENTAGE 
Non small cell carcinoma 17 36% 
Squamous cell carcinoma 13 28% 
Adenocarcinoma 7 15% 
Large cell Carcinoma 3 6.3% 
Undifferentiated carcinoma 3 6.3% 
Small cell Carcinoma 1 2% 
Pleural carcinoma 3 6.3% 
Total 47 100% 
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YIELD OF USG GUIDED FNAC VS YIELD OF BRONCHIAL WASH RESULTS: 
      All patients with non resolving consolidation in my study also underwent bronchoscopy 
which was routinely done to find out the etiology in our department of chest medicine. 
Bronchial wash and cytology were also taken and analyzed to find out microbial growth, Acid 
fast bacillus staining and cytological analysis. In 62 cases yield of bronchoscopy was meager 
2% (n=1) when compared to USG guided FNAC which yielded 95%(N=59)(Figure 26).USG 
guided FNAC was not helpful in 5%(n=3) cases in contrast to bronchial wash which was not at 
all useful in majority of cases 98%(n=61).this was probably due to the fact that lesions were 
more peripherally placed than in center of lung parenchyma. 
 
 
 
Figure 26:Comparison Of FNAC And Bronchial Wash
STATISTICAL ANALYSIS : 
Sensitivity of test means ability of a test to find out patients with the disease
enstivity of ideal diagnostic test should be 100%.but this is not always possible due 
to many factors associated with standardization of instrument and person who 
perform the test, sample collected
             In my study  after collection of results obtained from 
FNAC,SENSITIVITY OF TEST was 100% with signicant p value of  less than 0.0001% 
according to McNemar Test which statistically non significan
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statistical method used to compare two categorical variables. In my study  2 variables 
were results obtained in USG guided FNAC and  BRONCHIAL WASH ANALYSIS. 
McNemar test is a  2 × 2 contingency tables with matched pairs of subjects, to 
determine whether the row and column marginal frequencies are equal. 
           Positive predictive value(NPV)  which means   the probability that patient  with 
positive test truly  have the disease was 93% which highlights the diagnostic ability 
USG guided FNAC. From statistical analysis of my data ,it was clearly shown that  
there is SIGNIFICANT diagnostic accuracy and effectiveness of ULTRASOUND guided 
FNAC IN NON RESOLVING PENUMONIA  
STATISTICAL (Table 6):  
  
  
  
  
BRONCHIAL WASH  
   
Positive Negative  
FNAC  Positive 1 57  
Negative 0 4  
McNemar Test 
P value  
<0.0001 
SENSITIVITY (Table 7) : 
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Sensitivity Specificity PPV NPV 
100% 7% 2% 100% 
Sensitivity of my study was 100% 
FPR 0.934426 False positive rate 
FNR 0 
False negative 
 
 
 False positive rate which means   A test  result  appears positive when it should be.In my study false positive 
rate is  0.93 which is ideal for a DIAGNOSTIC test  
INCIDENCE OF COMPLICATION: 
 Patient who underwent ULTRASOUND GUIDED FNAC were requested for chest xray. 
Out of 62 patients one patient had radiographic evidence of loculated pneumothorax,(table 
7) but the patients was clinically stable. Patient was observed for a week in the ward and 
treated without ICD AND DISCHARGED.NO PATIENTS had bleeding complication. There was 
no other complication such as hemoptysis and bleeding. 
 
 NO YES 
PNEUMOTHORAX 61 (98.4%) 1 (1.6%) 
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INCIDENCE OF PNEUMOTHORAX(Figure : 27)
 
Figure 27: Incidence Of Pneumothorax 
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DISCUSSION 
 
 
 
 
 
 
82 
 
DISCUSSION:    
 Ultrasound is a easy to handle,reliable ,radiation and electromagnetic radiation free 
diagnostic test. Sensitivity of USG guided FNAC in my study population was 100 percent. This  
is comparable to Qian-jing hu et al’s bivariate meta analysis of 9 different study series of 
ultrasound guided FNAC  which came to conclusion that sensitivity was 97%.sensitivity of 
USG guided FNAC in nahar begum et al was 91.2%.In indian pretext shivani et al study on 
USG guided FNAC  showed  a diagnostic efficacy of 91.3% which is comparable to my 
study(figure 28). 
 
 
Figure 28: comparison of sensitivity of all studies 
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       Diagnostic accuracy of ultrasound guided FNAC of my study  was  95.2% whereas  
diagnostic accuracy of nahar begum et al study done at  Rajsahi was  93.8%. My study 
showed diagnostic accuracy compared to Mohammed et al  (2006) which had 97%  
accuracy, Gouliamos et al(2000) study group which had a diagnostic accuracy of 98.4% and 
Stanley et al study group with 96.6%(figure 29). 
 
Figure 29:comparison of diagnostic accuracy 
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         Complication rate in nahar begum et al was 6.6%  for  pneumothorax. Incidence of 
pneumothorax in Stanley et al, mohammed et al,gouliamos et al were 29%,1.1%,3.1% 
respectively. In my study incidence of pneumothorax was 1.6%(n=1).this was comparable 
to the above studies(figure 30). 
 
      Figure 30: Comparison Of Complication Rate 
       There was no incidence of hemoptysis, bleeding complications, death due to FNAC in 
my study as compared to Nahar Begum et al where one patient died due FNAC,3.8% patients 
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had hemoptysis and 2.8% patients had haemorrhage.in Stanley et al study group incidence of 
hemoptysis was 1.1%.5.4% patients in Mohammed et al study group had hemoptysis. In 
Gouliamos et al study group 1.6% had bleeding  complication. 
ETIOLOGY OF NON RESOLVING PNEUMONIA IN MY STUDY 
             
FIGURE 31:COMMON ETIOLOGIES OF NON RESOLVING PNEUMONIA IN MY STUDY 
Most common cause of non resolving pneumonia in my study group was lung malignancy 
76% followed by granulomatous lesion probably tuberculosis 8%. Dysplasia, infective 
pathogens and benign lesion such thymoma and schwanoma contributed to 4% each 
respectively(figure 31). Since our institution is tertiary care hospital, referral cases which 
were managed by initially  by general physicians with no resolution of pulmonary 
consolidation even with ATT and empirical antibiotic probably were referred  to us. This could 
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be reason for high incidence of malignancy. More over in our part of the world, smoking is an 
epidemic making probability of getting malignancy high. 
ETIOLOGY OF NON RESOLVING PNEUMONIA IN JEYAPRAKASH STUDY 
 
FIGURE 32: ETIOLOGIES  OF  NON RESOLVING  CONSOLIDATION  IN  JEYAPRAKASH  STUDY 
In contrast to our study, most common etiology of non resolving pneumonia in Jeyaprakash 
et al study in Trivandrum medical college which is 400 kms from our institution was 
tuberculosis (35.7%)  and malignancy (27%) reason for this disparity can be attributed to 
diabetes endemic in that region which contributes to tuberculosis. 
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      In  chest hospital Vishakpattnam, Andra Pradesh ,out of 30 cases diagnosed with non 
resolving pneumonia,10 were diagnosed to have tuberculosis out of 4 were diagnosed by 
FNAC of the lesion either by CT or USG guided. In 9 cases diagnosed with malignancy ,5 cases 
were diagnosed with FNAC establishing importance of image guided FNAC. 
       Analysing the cytological distribution of malignancy In my study and Hayder et al study 
whose study had relatively similar incidence of lung malignancy(57 out Of 75 Cases)  in USG 
Guided FNAC, non small cell Carcinoma(N=15) Was Predominant In my study compared to 
squamous cell carcinoma(n=35) in hyder et al study group. Incidence of adenocarcinoma was 
more in hyder et al group. incidence of small cell carcinoma was comparable in both studies 
(Figure 33). 
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In Hyder et al Study Group(figure 33) 
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CONCLUSION 
 TO CONCLUDE MY STUDY,FOLLOWING FINDINGS WERE OBSERVED: 
1. SENSITIVITY OF USG GUDED FNAC IN DIAGNOSING NON RESOLVING PNEUMONIA WAS 
100% WHICH MAKES USG GUIDED FNAC AS IDEAL DIAGNOSTIC INVESTIGATION 
2. COMPLICATION RATE FOR USG GUIDED FNAC WAS 1.6% WHICH WAS VERY NEGLIBLE 
COMPARING TO TRANSTHORACIC BIOPSY WHICH IS THE GOLD STANDARD TEST 
3. FOR NON RESOLVING CONSOLIDATION SITUATED ADJACENT TO CHEST WALL USG 
GUIDED FNAC IS INVESTIGATION OF CHOICE THAN BRONCHOSCOPY 
 4. USG GUIDED FNAC CAN BE DONE BY PULMONOLOGIST AND TREATING PHYSCIAN WITH 
MINIMAL TRAINING WITHOUT THE COMPLICATION IN DAY CARE CLINICS. 
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